» Articles » PMID: 7553888

Induction of IL-6 and IL-10 Production by Recombinant HIV-1 Envelope Glycoprotein 41 (gp41) in the THP-1 Human Monocytic Cell Line

Overview
Journal Cell Immunol
Publisher Elsevier
Date 1995 Oct 15
PMID 7553888
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Elevated levels of circulating monokines (IL-6, IL-1, and TNF alpha) have been seen in HIV-1 infection, and the overproduction of these cytokines could contribute to AIDS pathogenesis in various ways. In previous work, we had seen that exposure of human monocytes to HIV-1, including inactivated, noninfectious HIV, led to rapid IL-6 gene expression and secretion. To investigate cytokine production in response to components of HIV by monocytes/macrophages, production of IL-6 and IL-10 were examined in a human monocytic cell line, THP-1, stimulated by HIV proteins. IL-6 production was induced in THP-1 cells by a detergent lysate of HIV, particularly fractions at molecular weight of 25-50 kDa. Recombinant HIV envelope glycoprotein 41 (gp41), but not gp120 or p24, also was seen to induce significant IL-6 production by THP-1 cells. These results suggest that gp41, transmembrane protein, is the primary HIV-encoded protein involved in inducing IL-6 production. IL-10 was also produced with delayed kinetics, following IL-6 production in THP-1 cells stimulated by gp41. To investigate a possible regulatory role for IL-10 in HIV-induced monokine production, recombinant IL-10 was added to gp41-exposed THP-1 cells. IL-10 inhibited gp41-induced IL-6 production and reduced the expression of IL-6 mRNA. When anti-human IL-10 neutralizing antibody was added to THP-1 cells, IL-6 production was enhanced. These results suggest that the IL-6 production may be downregulated by endogenously produced IL-10 and that IL-10 may downregulate cytokine production by HIV-activated monocytes via an autoregulatory mechanism.

Citing Articles

Co-infection of syphilis and hepatitis B with carcinoma penis in a human immunodeficiency virus male.

Govindan B, Subramanian K, Karunakaran M Indian J Sex Transm Dis AIDS. 2017; 38(1):78-80.

PMID: 28442809 PMC: 5389221. DOI: 10.4103/0253-7184.194321.


Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1.

Muhle M, Lehmann M, Hoffmann K, Stern D, Kroniger T, Luttmann W PLoS One. 2017; 12(3):e0173454.

PMID: 28282446 PMC: 5345815. DOI: 10.1371/journal.pone.0173454.


Insulin Treatment Prevents Neuroinflammation and Neuronal Injury with Restored Neurobehavioral Function in Models of HIV/AIDS Neurodegeneration.

Mamik M, Asahchop E, Chan W, Zhu Y, Branton W, McKenzie B J Neurosci. 2016; 36(41):10683-10695.

PMID: 27733618 PMC: 6601935. DOI: 10.1523/JNEUROSCI.1287-16.2016.


Association of Toll-like receptor polymorphisms with HIV status in North Americans.

Willie B, Hall N, Stein C, Jurevic R, Weinberg A, Mehlotra R Genes Immun. 2014; 15(8):569-77.

PMID: 25253287 PMC: 4257894. DOI: 10.1038/gene.2014.54.


HIV-1 gp120 activates the STAT3/interleukin-6 axis in primary human monocyte-derived dendritic cells.

Del Corno M, Donninelli G, Varano B, Da Sacco L, Masotti A, Gessani S J Virol. 2014; 88(19):11045-55.

PMID: 25008924 PMC: 4178808. DOI: 10.1128/JVI.00307-14.